161 related articles for article (PubMed ID: 34537313)
1. Hypofractionated Stereotactic Radiation Therapy for Intact Brain Metastases in 5 Daily Fractions: Effect of Dose on Treatment Response.
Myrehaug S; Hudson J; Soliman H; Ruschin M; Tseng CL; Detsky J; Husain Z; Keith J; Atenafu EG; Maralani P; Heyn C; Das S; Lipsman N; Sahgal A
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):342-350. PubMed ID: 34537313
[TBL] [Abstract][Full Text] [Related]
2. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
[TBL] [Abstract][Full Text] [Related]
3. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
[TBL] [Abstract][Full Text] [Related]
4. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS).
Yan M; Lee M; Myrehaug S; Tseng CL; Detsky J; Chen H; Das S; Yeboah C; Lipsman N; Costa LD; Holden L; Heyn C; Maralani P; Ruschin M; Sahgal A; Soliman H
J Neurooncol; 2023 Mar; 162(1):119-128. PubMed ID: 36914878
[TBL] [Abstract][Full Text] [Related]
6. Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.
Faruqi S; Ruschin M; Soliman H; Myrehaug S; Zeng KL; Husain Z; Atenafu E; Tseng CL; Das S; Perry J; Maralani P; Heyn C; Mainprize T; Sahgal A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):772-779. PubMed ID: 31928848
[TBL] [Abstract][Full Text] [Related]
7. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control.
Ishihara T; Yamada K; Harada A; Isogai K; Tonosaki Y; Demizu Y; Miyawaki D; Yoshida K; Ejima Y; Sasaki R
Strahlenther Onkol; 2016 Jun; 192(6):386-93. PubMed ID: 27169391
[TBL] [Abstract][Full Text] [Related]
9. A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis.
Remick JS; Kowalski E; Khairnar R; Sun K; Morse E; Cherng HR; Poirier Y; Lamichhane N; Becker SJ; Chen S; Patel AN; Kwok Y; Nichols E; Mohindra P; Woodworth GF; Regine WF; Mishra MV
Radiat Oncol; 2020 May; 15(1):128. PubMed ID: 32466775
[TBL] [Abstract][Full Text] [Related]
10. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B; Kahn SE; Olson JJ; Shu HG; Crocker IR; Curran WJ; Patel KR
Pract Radiat Oncol; 2020; 10(1):36-43. PubMed ID: 31586666
[TBL] [Abstract][Full Text] [Related]
13. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters.
Jiang XS; Xiao JP; Zhang Y; Xu YJ; Li XP; Chen XJ; Huang XD; Yi JL; Gao L; Li YX
Radiat Oncol; 2012 Mar; 7():36. PubMed ID: 22429918
[TBL] [Abstract][Full Text] [Related]
15. Outcomes Following Hypofractionated Stereotactic Radiotherapy to the Cavity After Surgery for Melanoma Brain Metastases.
Gallo J; Garimall S; Shanker M; Castelli J; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):179-186. PubMed ID: 34642065
[TBL] [Abstract][Full Text] [Related]
16. Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
Sneed PK; Chan JW; Ma L; Braunstein SE; Theodosopoulos PV; Fogh SE; Nakamura JL; Boreta L; Raleigh DR; Ziemer BP; Morin O; Hervey-Jumper SL; McDermott MW
J Neurosurg; 2023 Jan; 138(1):104-112. PubMed ID: 35594891
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases.
Manning MA; Cardinale RM; Benedict SH; Kavanagh BD; Zwicker RD; Amir C; Broaddus WC
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):603-8. PubMed ID: 10837942
[TBL] [Abstract][Full Text] [Related]
18. Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients.
Laufer I; Iorgulescu JB; Chapman T; Lis E; Shi W; Zhang Z; Cox BW; Yamada Y; Bilsky MH
J Neurosurg Spine; 2013 Mar; 18(3):207-14. PubMed ID: 23339593
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation.
Eaton BR; Gebhardt B; Prabhu R; Shu HK; Curran WJ; Crocker I
Radiat Oncol; 2013 Jun; 8():135. PubMed ID: 23759065
[TBL] [Abstract][Full Text] [Related]
20. Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm.
Chon H; Yoon K; Lee D; Kwon DH; Cho YH
J Neurooncol; 2019 Oct; 145(1):49-56. PubMed ID: 31420793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
